No Data
Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Fly 27% But Investors Aren't Buying For Growth
The Three-year Loss for Pacira BioSciences (NASDAQ:PCRX) Shareholders Likely Driven by Its Shrinking Earnings
Express News | RBC Capital Maintains Sector Perform on Pacira BioSciences, Raises Price Target to $15
Does Pacira BioSciences (NASDAQ:PCRX) Have A Healthy Balance Sheet?
Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
Executive Reshuffles: NSC, PCRX and OMI Companies in Focus